Changes in Beneficial Ownership · 4
Cellebrite DI Ltd.
CLBTNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-17
- Issuer
- Cellebrite DI Ltd.
- Issuer CIK
- 0001854587
- Trading symbol
- CLBT
Reporting owner 1
- Name
- CLAMMER ADAM
- Reporting owner CIK
- 0001192808
- Relationship
- Director
- Address
- FOUR EMBARCADERO CENTER, SUITE 2100, SAN FRANCISCO, CA, 94111
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary shares, par value NIS 0.00001 | 2026-09-17 | A · Form 4 | 15,190[F1] | A | 0 | 86,586 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Ordinary shares, par value NIS 0.00001 | 13,861,007[F2] | I | By TWC Tech Holdings II, LLC[F3][F4] |
| Ordinary shares, par value NIS 0.00001 | 375,000 | I | By Long Term Trust[F4] |
| Ordinary shares, par value NIS 0.00001 | 375,000 | I | By Joint Revocable Trust[F4] |
Table key
- I
- Indirect
Footnotes
- F1
- Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.↩ 1
- F2
- Includes 1,500,000 Ordinary Shares of the Issuer subject to transfer restrictions pending the satisfaction of certain performance-based vesting conditions.↩ 1
- F3
- As one of the managing members of the ultimate controlling entity of TWC Tech Holdings II, LLC, Mr. Clammer may be deemed to have shared beneficial ownership of the securities held directly by TWC Tech Holdings II, LLC.↩ 1
- F4
- Mr. Clammer disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, Mr. Clammer states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.↩ 1↩ 2↩ 3
Signature 1
- Signed
- /s/ Sara Bockey, Attorney-in-Fact
- Date
- 2026-09-28
Company context
Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.